董佑红，男，1973年6月生，主任医师，副教授，硕士研究生导师，襄阳市“隆中名医”，湖北医药学院附属襄阳市第一人民医院肿瘤科主任；中国抗癌协会肿瘤热疗专业委员会肿瘤热化疗灌注专家委员会常务委员，湖北省抗癌协会肿瘤免疫治疗专业委员会副主任委员，湖北省微循环学会肿瘤专业委员会第一届委员会常务委员，湖北省抗癌协会第七届理事会常务理事。 长期从事肿瘤的规范化诊疗，并围绕肿瘤发生及治疗开展相关病理机制研究，主持及参与国自然、省级科研项目及临床研究项目多项，主持完成湖北省科学技术进步三等奖1项（2023年，靶向肿瘤免疫微环境和免疫重塑在多维抗肿瘤中的创研与应用），发表学术文章20余篇，其中SCI 10多篇；以副主编著有著作《新编肿瘤科临床应用指南》一部；近年论文列表如下： 1. Zhang D, Han Y,Dong Y. Remarkable response to chidamide plus rituximab in an elderly patient with recurrent, chemotherapy-refractory diffuse larger B-cell lymphoma carrying CREBBP mutation. Ann Hematol. 2023 May;102(5):1265-1268. doi: 10.1007/s00277-023-05183-9. Epub 2023 Mar 29. PMID: 36991230. 2. Zhang D, Han Y,Dong Y. Can we restart the rituximab after remission of rituximab-induced interstitial lung disease in malignant lymphoma? Ann Hematol. 2022 Oct;101(10):2373-2375. doi: 10.1007/s00277-022-04913-9. Epub 2022 Jul 1. PMID: 35776168. 3. Dong Y, Zahid KR, Han Y, Hu P, Zhang D. Treatment of Pediatric Inflammatory Myofibroblastic Tumor: The Experience from China Children's Medical Center. Children (Basel). 2022 Feb 24;9(3):307. doi: 10.3390/children9030307. PMID: 35327685; PMCID: PMC8947196. 4. Zhang D, Zhu Y, Jin Y, Kaweme NM,Dong Y. Leukapheresis and Hyperleukocytosis, Past and Future. Int J Gen Med. 2021 Jul 14;14:3457-3467. doi: 10.2147/IJGM.S321787. PMID: 34285568; PMCID: PMC8286901. 5. Zhang D, Liu Y, Wu Q, Zheng Y, Kaweme NM, Zhang Z, Cai M,Dong Y. Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1. J Cancer. 2021 Mar 15;12(10):2952-2959. doi: 10.7150/jca.53356. PMID: 33854595; PMCID: PMC8040896. 6. Chen Q, Chen R,Dong Y. Inhibitory effect of endostar combined with radiotherapy on gastric cancer animal models. World J Surg Oncol. 2020 Jul 15;18(1):165. doi: 10.1186/s12957-020-01937-1. PMID: 32669133; PMCID: PMC7364530. 7. Chen R, Chen QT,Dong YH. Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17. Oncol Lett. 2019 Jun;17(6):5447-5452. doi: 10.3892/ol.2019.10270. Epub 2019 Apr 18. PMID: 31186764; PMCID: PMC6507486. 8. Zhang L, Zuo M, Ma X,Dong Y. Effects of neoadjuvant chemotherapy on minimum alveolar concentration values of sevoflurane and desflurane in patients with hepatocellular carcinoma complicated with jaundice. Oncol Lett. 2018 Jul;16(1):388-394. doi: 10.3892/ol.2018.8621. Epub 2018 May 2. PMID: 29928426; PMCID: PMC6006300. |
